Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001610717-23-000068
Filing Date
2023-05-25
Accepted
2023-05-25 19:32:17
Documents
1
Period of Report
2023-05-23

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 4099
  Complete submission text file 0001610717-23-000068.txt   5657
Mailing Address C/O IGNYTA, INC. 11095 FLINTKOTE AVE., SUITE D SAN DIEGO CA 92121
Business Address
Chacko Jacob (Reporting) CIK: 0001608936 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39782 | Film No.: 23962605

Mailing Address 5858 HORTON STREET #455 EMERYVILLE CA 94608
Business Address 5858 HORTON STREET #455 EMERYVILLE CA 94608 5105052680
4D Molecular Therapeutics, Inc. (Issuer) CIK: 0001650648 (see all company filings)

EIN.: 473506994 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)